
|
Derived from the achievement of our R&D, our biomedical products treat underlying disease causes of 80% disease without known side effect, including malignant and chronic diseases. Our biomedical products, known as US OncoTherapy MediFormula, are in the realm of the following definition: |
The legal definition in section 201 of the Federal Food, Drug and Cosmetic Act: |
ˇ§Biomedical products refer primarily to medical devices, which are an instrument, apparatus, implement, machine, contrivance, Implant, in-vitro reagent, or other similar or related article, including any component, part, or accessory which is recognized in the official National Formulary, or the United States Pharmacopia, or any supplement to them, intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation treatment or prevention of disease; or intended to affect the structure or any function of the body, and does not achieve its primary intended purpose through chemical action and is not dependent upon being metabolized for the achievement of its primary intended purpose. ˇ¨ |
Different than chemical drugs designed to one single therapeutic indication's efficacy, the US OncoTherapy MediFormula is well-designed molecular-based biomedical products with Pleiotropic Pharmacodynamics Discovery (PPD) on polypeptide, glycoproteins, and biotechnology-purified botanical and herbal glycosides for biomedical compound prescription, which is developed based on our innovation in Assembler Code & Collating Platform of Systems Biology (known as US OncoTherapy Medicine ACCP/SB). |
Without known side effect, nowadays above 50 MediFormula have been developed in US OncoTherapy MediFormula to treat more than one hundred colonies of cytopathogenetic causes, which are the underlying disease causes of 80% disease, including malignant disease, chronic diseases, and single/ multi- diseases.
|
The US OncoTherapy MediFormula is nonprescription drug, with material ingredient of PolyPeptide, GlycoProteins, and botanical and herbal glycosides to act as human biological response modifiers and rectifiers to diseases. |
|
|
|